In fact, IGF-1R, the upstream receptor of IRS-1, has been suggested to be a potential therapeutic target in GIST [36], in addition to being a diagnostic marker for non-intestinal GIST [14]. Here, IRS1 is linked to gastrointestinal stromal tumor.